These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 11364951)
1. 1998 outlook: treatment; research; access. James JS AIDS Treat News; 1998 Jan; (No 286):1-5. PubMed ID: 11364951 [TBL] [Abstract][Full Text] [Related]
2. 1999: treatments, issues to watch. James JS AIDS Treat News; 1999 Jan; (No 310):1-3. PubMed ID: 11366149 [TBL] [Abstract][Full Text] [Related]
3. Adefovir dipivoxil (Preveon) expanded access restrictions being eased. James JS AIDS Treat News; 1998 Feb; (No 288):4-5. PubMed ID: 11365045 [TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
5. Restoring HIV-specific immunity. James JS AIDS Treat News; 1999 Feb; (No 312):2-6. PubMed ID: 11366200 [TBL] [Abstract][Full Text] [Related]
6. New drug in expanded access. Vazquez E Posit Aware; 1998; 9(1):16. PubMed ID: 11364994 [TBL] [Abstract][Full Text] [Related]
7. Summaries from the Eleventh Annual Houston Conference on AIDS in America. Res Initiat Treat Action; 1999 Jul; 5(3):13-25. PubMed ID: 11366719 [TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy: coping with failure, planning for success. Gallant JE Posit Aware; 1998; 9(3):51-2, 55-7. PubMed ID: 11365489 [TBL] [Abstract][Full Text] [Related]
11. Expanding access to investigational new therapies. Cohen C; Shevitz A; Mayer K Prim Care; 1992 Mar; 19(1):87-96. PubMed ID: 1594704 [TBL] [Abstract][Full Text] [Related]
12. Glaxo opens broad expanded access program for abacavir (Ziagen). Baker R BETA; 1998 Apr; ():6. PubMed ID: 11365271 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic options or antiretroviral anarchy? Mascolini M J Int Assoc Physicians AIDS Care; 1999 Jan; 5(1):10-30. PubMed ID: 11366158 [TBL] [Abstract][Full Text] [Related]
14. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients. Rodes B; GarcĂa F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V; J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728 [TBL] [Abstract][Full Text] [Related]
15. Adefovir dipivoxil (Preveon) new results with hepatitis B, HIV. James JS AIDS Treat News; 1998 Apr; (No 293):6-7. PubMed ID: 11365389 [TBL] [Abstract][Full Text] [Related]
16. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
17. When paradigms fall: the demise of "hit hard, hit early". Simmons P Res Initiat Treat Action; 1999 Dec; 5(5):11-2. PubMed ID: 11366884 [TBL] [Abstract][Full Text] [Related]
18. Expanded and early access and patient assistance programs for other experimental drugs from their manufacturers. Crit Path AIDS Proj; 1998; (No 33):43-64. PubMed ID: 11366373 [TBL] [Abstract][Full Text] [Related]